Impaired CD4 T-Cell Count Response to Combined Antiretroviral Therapy in Antiretroviral-Naive HIV-Infected Patients Presenting With Tuberculosis as AIDS-Defining Condition
Author(s) -
Antonella Cingolani,
Alessandro Cozzi Lepri,
Antonella Castagna,
Delia Goletti,
Andrea De Luca,
P. Scarpellini,
Iuri Fanti,
Andrea Antinori,
Antonella d’Arminio Monforte,
Enrico Girardi
Publication year - 2011
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cir900
Subject(s) - medicine , tuberculosis , cart , viral load , immunology , confounding , hazard ratio , antiretroviral therapy , human immunodeficiency virus (hiv) , pathology , confidence interval , mechanical engineering , engineering
The impact of human immunodeficiency virus (HIV)-associated tuberculosis on CD4 T-cell count response to combined antiretroviral therapy (cART) is poorly investigated.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom